Hu, Fang <br/><br/>
Lung adenocarcinoma resistance to therapy with EGFR‑tyrosine kinase inhibitors is related to increased expression of cancer stem cell markers SOX2, OCT4 and NANOG.  [electronic resource] 

 -  Oncology reports  02 2020 
 - 727-735 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-2431 
<br/><br/><label>Standard No.: </label>10.3892/or.2019.7454  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma of Lung--drug therapy<br/>Adult<br/>Aged<br/>Drug Resistance, Neoplasm<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Nanog Homeobox Protein--genetics<br/>Neoplastic Stem Cells--metabolism<br/>Octamer Transcription Factor-3--genetics<br/>Protein Kinase Inhibitors--pharmacology<br/>Retrospective Studies<br/>SOXB1 Transcription Factors--genetics<br/>Up-Regulation